Balance Sheet for Clementia Pharmaceuticals Inc. (CMTA)

$ N/A N/A (N/A) Volume: 0 N/A
Statement: View:
Assets [+] in Thousands of Dollars
12/2018 12/2017 12/2016 12/2015 12/2014
Cash and Equivalents 94,973 36,230 9,434 58,107 5,504
Restrictable Cash - - - - -
Marketable Securities 75,000 30,000 30,000 - -
Accounts Receivable 1,760 1,648 538 424 367
Loans Receivable - - - - -
Other Receivables - - - - -
Receivables 1,760 1,648 538 424 367
Inventories, Raw Materials - - - - -
Inventories, Work in Progress - - - - -
Inventories, Purchased Components - - - - -
Inventories, Finished Goods - - - - -
Inventories, Other - - - - -
Inventories, Adjustments & Allowances - - - - -
Inventories - - - - -
Prepaid Expenses 2,407 3,023 652 1,048 1,068
Current Deferred Income Taxes - - - - -
Other Current Assets - - - - -
Total Current Assets 174,140 70,901 40,624 59,580 6,939
Land and Improvements - - - - -
Buildings and Improvement - - - - -
Machinery, Furniture and Equipment - - - - -
Construction in Progress - - - - -
Fixed Assets, Other 8 33 38 45 11
Fixed Assets, Total 8 33 38 45 11
Gross Fixed Assets 8 33 38 45 11
Accumulated Depreciation - - - - -
Net Fixed Assets 8 33 38 45 11
Intangibles 1,667 1,715 895 1,032 1,050
Cost in Excess - - - - -
Non-Current Deferred Income Taxes - - - - -
Other Non-Current Assets - - - - -
Total Non-Current Assets 2,704 77,524 933 1,077 1,061
Total Assets 176,844 148,425 41,557 60,657 8,000
Liabilities [+] in Thousands of Dollars
12/2018 12/2017 12/2016 12/2015 12/2014
Accounts Payable 12,412 6,719 4,522 4,010 1,960
Short Term Debt - - - - -
Notes Payable - - - - -
Accrued Expenses - - - - -
Accrued Liabilities - - - - -
Deferred Revenues - - - - -
Current Deferred Income Taxes 381 (79) 48 - -
Other Current Liabilities - - 2 - 94
Total Current Liabilities 12,412 6,719 4,524 4,010 2,054
Long Term Debt - - - - -
Deferred Income Tax - - - - -
Other Non-Current Liabilities - - 117,825 83,843 7,491
Minority Interest - - - - -
Capital Lease Obligations - - - - -
Preferred Securities of Subsidiary Trust - - - - -
Preferred Equity Outside Shareholders' Equity - - 67,881 64,139 14,107
Total Non-Current Liabilities - - 185,706 147,981 21,598
Total Liabilities 12,412 6,719 190,229 151,992 23,653
Preferred Shareholder's Equity - - - - -
Common Shareholder's Equity 164,432 141,707 (148,672) (91,335) (15,652)
Common Par - - - - -
Additional Paid in Capital 314,171 233,319 771 596 382
Cumulative Translation Adjustments - - - - -
Retained Earnings (149,739) (91,612) (149,443) (91,931) (16,034)
Treasury Stock - - - - -
Other Equity Adjustments - - - - -
Total Capitalization 164,432 141,707 (148,672) (91,335) (15,652)
Total Equity 164,432 141,707 (148,672) (91,335) (15,652)
Total Liabilities & Shareholder's Equity 176,844 148,425 41,557 60,657 8,000
Cash Flow (58,126) (118,139) (61,427) (78,425) (13,751)
Working Capital 161,727 64,183 36,101 55,569 4,885
Free Cash Flow (49,285) (36,587) (18,856) (17,788) (9,797)
Invested Capital 164,432 141,707 (148,672) (91,335) (15,652)
Shares Outstanding - Common Class Only 37,864 31,718 - - -
Preferred Shares Outstanding - - - - -
Total Ordinary Shares 37,864 31,718 31,718 29,677 29,677
Total Common Shares Outstanding 37,864 31,718 - - -
Treasury Shares - - - - -
Basic Weighted Shares Outstanding 32,714 14,560 21,586 21,731 21,731
Diluted Weighted Shares Outstanding 32,714 14,560 21,586 21,731 21,731